FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Forest Pharmaceuticals Bystolic Recall

Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12…

Forest Pharmaceuticals Inc · Earth City, MO

Risk level
Class II
Reported by FDA
Oct 29, 2014
Recall ID
D-0036-2015
Check your lot numberHow we source this data

Summary

Forest Pharmaceuticals recalled Bystolic starting Sep 26, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0036-2015 on Oct 29, 2014. Reason: Failed Dissolution Specification; at the 6-month stability time point. Status: Terminated.

Why it was recalled

Failed Dissolution Specification; at the 6-month stability time point

Product description

Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07

Lot numbers, UPCs & expiration codes

Lot A369286, exp. date 31 Jan 2016

Where it was sold

Nationwide including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0036-2015
Classification
Class II
Status
Terminated
Recall initiated
Sep 26, 2014
FDA report date
Oct 29, 2014
Quantity
94,584 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Forest Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0036-2015, exactly as published.

Show all FDA fields
City
Earth City
State
MO
Status
Terminated
Country
United States
Event ID
69298
Address
13600 Shoreline Dr
Code information
Lot A369286, exp. date 31 Jan 2016
Postal code
63045-1220
Report date
Oct 29, 2014
Product type
Drugs
Recall number
D-0036-2015
Classification
Class II
Recalling firm
Forest Pharmaceuticals Inc
Product quantity
94,584 cartons
Termination date
Mar 29, 2017
Reason for recall
Failed Dissolution Specification; at the 6-month stability time point
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. --- NDC 0456-1420-07
Distribution pattern
Nationwide including Puerto Rico.
Recall initiation date
Sep 26, 2014
Initial firm notification
Letter
Center classification date
Oct 17, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0036-2015, published Oct 29, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls